文献速递儿童青少年精神

利用转化研究方法推动自闭症的诊疗进展

Leveraging a translational research approach to drive diagnostic and treatment advances for autism.
PubMed 文献 · Mol Psychiatry · 2022-04-01

自闭症谱系障碍(ASD)缺乏实验室诊断测试和改善核心症状的药物。研究者利用自然低社交的恒河猴建立模型,发现脑脊液加压素浓度是跨灵长类社交损伤的神经化学标志物,鼻内加压素在小型2a期试验中改善ASD儿童社交能力。该转化路径有望推广至其他缺乏有效临床前模型的人类脑部疾病。

要点

  • 脑脊液加压素浓度被确定为跨灵长类社交损伤的神经化学标志物。
  • 鼻内加压素在小型2a期试验中显示改善ASD儿童社交能力。
  • 该转化研究路径可适配于其他缺乏有效临床前模型的人类脑部疾病。

核心结论

  • 利用自然低社交恒河猴模型的转化研究路径,可推动ASD诊断与治疗进展,并可能推广至其他缺乏有效临床前模型的人类脑部疾病。

研究设计与样本

  • 研究者在大型户外饲养猴群中开展行为筛查与生物标志物鉴定,研究自然低社交恒河猴以模拟人类社交损伤,并验证动物模型,同时直接在ASD患者中评估临床前发现的转化效用。

主要发现

  • 脑脊液加压素浓度被确定为跨灵长类社交损伤的稳健神经化学标志物。
  • 鼻内加压素作为首创药物,在小型2a期试点试验中显示可改善ASD儿童的社交能力。

关键数值与推荐

  • 脑脊液加压素浓度为跨灵长类社交损伤的神经化学标志物。
  • 鼻内加压素在小型2a期试点试验中改善ASD儿童社交能力。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Autism spectrum disorder (ASD) is a prevalent and poorly understood neurodevelopmental disorder. There are currently no laboratory-based diagnostic tests to detect ASD, nor are there any disease-modifying medications that effectively treat ASD's core behavioral symptoms. Scientific progress has been impeded, in part, by overreliance on model organisms that fundamentally lack the sophisticated social and cognitive abilities essential for modeling ASD. We therefore saw significant value in studying naturally low-social rhesus monkeys to model human social impairment, taking advantage of a large outdoor-housed colony for behavioral screening and biomarker identification. Careful development and validation of our animal model, combined with a strong commitment to evaluating the translational utility of our preclinical findings directly in patients with ASD, yielded a robust neurochemical marker (cerebrospinal fluid vasopressin concentration) of trans-primate social impairment and a first-in-class medication (intranasal vasopressin) shown in a small phase 2a pilot trial to improve social abilities in children with ASD. This translational research approach stands to advance our understanding of ASD in a manner not readily achievable with existing animal models, and can be adapted to investigate a variety of other human brain disorders which currently lack valid preclinical options, thereby streamlining translation and amplifying clinical impact more broadly.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Parker KJ. Leveraging a translational research approach to drive diagnostic and treatment advances for autism. Mol Psychiatry. 2022. PMID: 35365807. doi:10.1038/s41380-022-01532-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。